SCHEMBL5963319

SCHEMBL5963319

CCOP(=O)(OCC)OC(F)(F)C(F)(F)C(F)(F)CF

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.43
TP53 P04637 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15301012 0.92 TSHR (0.36) TSHR
SCHEMBL15301166 0.91 TSHR (0.39) TSHR
SCHEMBL15301392 0.89 CYP3A4 (0.46) TSHR
SCHEMBL5963712 0.89 TSHR (0.46) TSHRTP53TDP1
SCHEMBL5963641 0.86 CYP3A4 (0.35) TSHR
SCHEMBL7262034 0.85 TSHR (0.46) TSHRTP53TDP1
SCHEMBL15301404 0.84
SCHEMBL5963428 0.83 CYP3A4 (0.50) TSHR
SCHEMBL5963315 0.81
SCHEMBL15301006 0.81 TSHR (0.39) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110326153-B Secondary battery and method of using the same 远景AESC能源元器件有限公司 2023-04-28 CN disclosed
CN-110637388-B Electrolyte for lithium ion secondary battery and lithium ion secondary battery using same 日本电气株式会社 2023-03-24 CN disclosed
US-11611107-B2 Lithium ion secondary battery NEC CORPORATION (JP) 2023-03-21 US disclosed
CN-110720156-B Lithium ion secondary battery 日本电气株式会社 2023-01-06 CN disclosed
US-11489202-B2 Electrolyte solution for lithium ion secondary battery and lithium ion secondary battery using same NEC CORPORATION (JP) 2022-11-01 US disclosed
CN-115275324-A Secondary battery and method for using secondary battery 远景AESC日本有限公司 2022-11-01 CN disclosed
US-11469454-B2 Secondary battery and method for using secondary battery Envision AESC Janan Ltd. (JP) 2022-10-11 US disclosed
CN-108701812-B Negative electrode for lithium secondary battery and lithium secondary battery 日本电气株式会社 2022-09-23 CN disclosed
CN-110291678-B Secondary battery and method for using secondary battery 远景AESC能源元器件有限公司 2022-09-16 CN disclosed
US-11329321-B2 Lithium ion secondary battery NEC CORPORATION (JP) 2022-05-10 US disclosed
EP-2876723-A1 LITHIUM SECONDARY BATTERY Nec Corporation (JP) 2015-05-27 EP disclosed
US-20150132663-A1 LITHIUM SECONDARY BATTERY NEC CORPORATION (JP) 2015-05-14 US disclosed
US-20150118577-A1 LITHIUM SECONDARY BATTERY NEC CORPORATION (JP) 2015-04-30 US disclosed
US-20150010831-A1 LITHIUM SECONDARY BATTERY NEC CORPORATION (JP) 2015-01-08 US disclosed
US-20140322615-A1 LITHIUM ION SECONDARY BATTERY NEC CORPORATION (JP) 2014-10-30 US disclosed
EP-2779297-A1 LITHIUM ION SECONDARY BATTERY NEC Corporation (JP) 2014-09-17 EP disclosed
EP-2650959-A1 LITHIUM SECONDARY BATTERY Nec Corporation (JP) 2013-10-16 EP disclosed
US-20130266847-A1 LITHIUM SECONDARY BATTERY NEC ENERGY DEVICES, LTD. (JP) 2013-10-10 US disclosed
US-20060172201-A1 Non-aqueous electrolyte and lithium secondary battery using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2006-08-03 US disclosed
EP-1357628-A1 NONAQUEOUS ELECTROLYTIC LIQUIDS AND LITHIUM SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2003-10-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11611107-B2 Lithium ion secondary battery SCO2, LPO, KCNN2 TSHR 2857/4885TP53 2145/4885TDP1 2460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.